BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 38501418)

  • 21. Upregulated circRNA_102231 promotes gastric cancer progression and its clinical significance.
    Yuan G; Ding W; Sun B; Zhu L; Gao Y; Chen L
    Bioengineered; 2021 Dec; 12(1):4936-4945. PubMed ID: 34374630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-29a inhibits cell proliferation and arrests cell cycle by modulating p16 methylation in cervical cancer.
    Wang A; Xu Q; Sha R; Bao T; Xi X; Guo G
    Oncol Lett; 2021 Apr; 21(4):272. PubMed ID: 33717269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ATP5B promotes the metastasis and growth of gastric cancer by activating the FAK/AKT/MMP2 pathway.
    Wang X; Chang X; He C; Fan Z; Yu Z; Yu B; Wu X; Hou J; Li J; Su L; Liu B; Zhu Z
    FASEB J; 2021 Apr; 35(4):e20649. PubMed ID: 33715234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PCID2, a subunit of the
    Glukhova AA; Kurshakova MM; Nabirochkina EN; Georgieva SG; Kopytova DV
    RNA Biol; 2021 Nov; 18(11):1969-1980. PubMed ID: 33602059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HOXA10 mediates epithelial-mesenchymal transition to promote gastric cancer metastasis partly via modulation of TGFB2/Smad/METTL3 signaling axis.
    Song C; Zhou C
    J Exp Clin Cancer Res; 2021 Feb; 40(1):62. PubMed ID: 33563300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
    Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
    CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population.
    So JBY; Kapoor R; Zhu F; Koh C; Zhou L; Zou R; Tang YC; Goo PCK; Rha SY; Chung HC; Yoong J; Yap CT; Rao J; Chia CK; Tsao S; Shabbir A; Lee J; Lam KP; Hartman M; Yong WP; Too HP; Yeoh KG
    Gut; 2021 May; 70(5):829-837. PubMed ID: 33028667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BRCA1-associated protein induced proliferation and migration of gastric cancer cells through MAPK pathway.
    Wei X; Liu X; Liu H; He X; Zhuang H; Tang Y; Wang B
    Surg Oncol; 2020 Dec; 35():191-199. PubMed ID: 32890957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of p27 and p16 and their clinical significance in gastric cancer.
    Kumari S; Kumar P; Kumar M; Singh S; Narayan G
    Clin Transl Oncol; 2021 Apr; 23(4):856-865. PubMed ID: 32880047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastric cancer.
    Smyth EC; Nilsson M; Grabsch HI; van Grieken NC; Lordick F
    Lancet; 2020 Aug; 396(10251):635-648. PubMed ID: 32861308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiRNA-12129 Suppresses Cell Proliferation and Block Cell Cycle Progression by Targeting SIRT1 in GASTRIC Cancer.
    Zhang W; Liao K; Liu D
    Technol Cancer Res Treat; 2020; 19():1533033820928144. PubMed ID: 32508267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNMT1 as a therapeutic target in pancreatic cancer: mechanisms and clinical implications.
    Wong KK
    Cell Oncol (Dordr); 2020 Oct; 43(5):779-792. PubMed ID: 32504382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of DOT1L in the proliferation and prognosis of gastric cancer.
    Song Z; Wei Z; Wang Q; Zhang X; Tao X; Wu N; Liu X; Qian J
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31939604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Silencing ELMO3 Inhibits the Growth, Invasion, and Metastasis of Gastric Cancer.
    Hu Y; Yu Q; Zhong Y; Shen W; Zhou X; Liu X; Xu M; Zhou N; Min W; Gao D
    Biomed Res Int; 2018; 2018():3764032. PubMed ID: 30345300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer.
    Feng F; Tian Y; Xu G; Liu Z; Liu S; Zheng G; Guo M; Lian X; Fan D; Zhang H
    BMC Cancer; 2017 Nov; 17(1):737. PubMed ID: 29121872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress in the treatment of advanced gastric cancer.
    Song Z; Wu Y; Yang J; Yang D; Fang X
    Tumour Biol; 2017 Jul; 39(7):1010428317714626. PubMed ID: 28671042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetics and Molecular Pathogenesis of Gastric Adenocarcinoma.
    Tan P; Yeoh KG
    Gastroenterology; 2015 Oct; 149(5):1153-1162.e3. PubMed ID: 26073375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognostic significance of pretreatment serum CEA levels in gastric cancer: a meta-analysis including 14651 patients.
    Deng K; Yang L; Hu B; Wu H; Zhu H; Tang C
    PLoS One; 2015; 10(4):e0124151. PubMed ID: 25879931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human TREX2 components PCID2 and centrin 2, but not ENY2, have distinct functions in protein export and co-localize to the centrosome.
    Cunningham CN; Schmidt CA; Schramm NJ; Gaylord MR; Resendes KK
    Exp Cell Res; 2014 Jan; 320(2):209-18. PubMed ID: 24291146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum carbohydrate antigen 19-9 and prognosis of patients with gastric cancer.
    Xiao J; He X; Wang Z; Hu J; Sun F; Qi F; Yang S; Xiao Z
    Tumour Biol; 2014 Feb; 35(2):1331-4. PubMed ID: 24234331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.